Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Cuneo

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Journal of Biomedicine & Biotechnology|June 2, 2011
Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphomaAntonella Bardi, Francesco Cavazzini, Gian Matteo Rigolin, et al.
Blood|June 7, 2003
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcomeGiuseppe Cimino, Loredana Elia, Marco Mancini, et al.
Cancer Research|February 8, 2005
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphomaMassimo Guidoboni, Paola Zancai, Roberta Cariati, et al.
Blood Cancer Journal|June 28, 2023
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines AgencyGian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
Frontiers in Psychology|March 8, 2019
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical TrialLidia Borghi, Sara Galimberti, Claudia Baratè, et al.
Oncology Reports|September 18, 2020
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Genes, Chromosomes & Cancer|January 28, 2016
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalitiesCarmen Baldazzi, Simona Luatti, Elisa Zuffa, et al.
Leukemia & Lymphoma|December 4, 2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapyAlice Di Rocco, Antonio Cuneo, Arianna Di Rocco, et al.
Human Immunology|December 20, 2011
Umbilical cord blood CD34(+)cell-derived progeny produces human leukocyte antigen-G molecules with immuno-modulatory functionsMarina Buzzi, Francesco Alviano, Diana Campioni, et al.
Oncology Reports|July 13, 2026
[Retracted] Kevetrin induces apoptosis in <i>TP53</i> wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Journal of Biomedicine & Biotechnology|June 2, 2011
Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphomaAntonella Bardi, Francesco Cavazzini, Gian Matteo Rigolin, et al.
Blood|June 7, 2003
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcomeGiuseppe Cimino, Loredana Elia, Marco Mancini, et al.
Cancer Research|February 8, 2005
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphomaMassimo Guidoboni, Paola Zancai, Roberta Cariati, et al.
Blood Cancer Journal|June 28, 2023
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines AgencyGian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
Frontiers in Psychology|March 8, 2019
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical TrialLidia Borghi, Sara Galimberti, Claudia Baratè, et al.
Oncology Reports|September 18, 2020
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Genes, Chromosomes & Cancer|January 28, 2016
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalitiesCarmen Baldazzi, Simona Luatti, Elisa Zuffa, et al.
Leukemia & Lymphoma|December 4, 2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapyAlice Di Rocco, Antonio Cuneo, Arianna Di Rocco, et al.
Human Immunology|December 20, 2011
Umbilical cord blood CD34(+)cell-derived progeny produces human leukocyte antigen-G molecules with immuno-modulatory functionsMarina Buzzi, Francesco Alviano, Diana Campioni, et al.
Oncology Reports|July 13, 2026
[Retracted] Kevetrin induces apoptosis in <i>TP53</i> wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Pageof 19